Clinical Trial Update: Abatacept in ANCA Associated Vasculitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating abatacept for ANCA-associated vasculitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Imperial College London | Conditions: ANCA-associated Vasculitis | Phase 2 | Status: TERMINATED